Skip to main content
SpringerLink
Log in

Hypertension in Diabetics with Renal Disease

  • Chapter
The Kidney and Hypertension in Diabetes Mellitus

Part of the book series: Topics in Renal Medicine ((TIRM,volume 6))

  • 64 Accesses

Abstract

Ever since the demonstration of high prevalence of hypertension in diabetics by Hitzenberger in 1921 [1], hypertension has been recognized as a major complication of diabetes. However, for a long time, it had remained the Cinderella of diabetology. Only recently, the mechanisms involved in the genesis of hypertension have been studied, its influence on progression of nephropathy has been recognized, and the necessity of rigorous blood pressure control both prior to renal failure and in advanced renal failure has been widely appreciated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hitzenberger K: Über den Blutdruck bei Diabetes mellitus. Wien Arch Inn Med 2: 461, 1921.

    Google Scholar 

  2. Hasslacher Ch, Rambausek M, Ritz E: Genesis and management of hypertension of diabetic nephropathy. In: Keen H, Legrain M (eds) prevention and treatment of diabetic nephropathy. MTP Press Limited, 1983, pp 177–189.

    Google Scholar 

  3. Weidmann P: Recent pathogenetic aspects in essential hypertension and hypertension associated with diabetes mellitus. Klin Wochenschr 58: 1071, 1980.

    Article  PubMed  CAS  Google Scholar 

  4. O’Hare JA, Ferriss JB, Brady D, Twomey B, O’Sullivan DJ: Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension [Suppl 2] 7: 43–48, 1985.

    Article  Google Scholar 

  5. O’Hare JP, Roland JM, Walters G, Corrall RJM: Impaired sodium excretion in response to volume expansion induced by water immersion in non-insulin-dependent diabetes mellitus. Clin Sci 71: 403–409, 1986.

    PubMed  Google Scholar 

  6. Sawicki P, Heinemann L, Rave K, Hohmann A, Tilwix F, Berger M: Erhöhte a-ANP Konzentrationen bei Hypertonen Typ-I-Diabetikern, Abhängigkeit vom Grad der Nephropathie. Hochdruck 8:32(a), 1986 [10. Wissenschaftliche Tagung Dtsch. Ges. zur Bekämpfung des Hohen Blutdrucks, Münster, November 1986 ].

    Google Scholar 

  7. De Chatel R, Toth M, Barna I, Büki B, Lang RE: Differential responses in atrial natriuretic peptide and urinary sodium excretion following an intravenous saline load in normal man and in patients with diabetes mellitus. Hochdruck 8:31(a), 1986 [ibid].

    Google Scholar 

  8. Walter-Schräder M-C, Jungmann E, Haak T, Rosak C, Schwab N, Fassbinder W, Althoff PH, Schöffling K: Verminderte natriuretische Wirksamkeit des humanen atrialen natriuretischen Peptides (hANP) bei Patienten mit Typ I Diabetes mellitus. Hochdruck 8:31(a), 1986 [ibid].

    Google Scholar 

  9. Drury PL, Smith GM, Ferriss JB: Increased vascular responsiveness to angiotensin II in type I (insulin-dependent) diabetic patients without complications. Diabetologia 27: 174–179, 1984.

    PubMed  CAS  Google Scholar 

  10. Christlieb AR, Kaldany A, D’Elia JA, Williams GE: Aldosterone responsiveness in patients with diabetes mellitus. Diabetes 27: 732–737, 1978.

    Article  PubMed  CAS  Google Scholar 

  11. Tornita K, Matsuda O, Ideura T, Shiigai T, Takeuchi J: Renin—angiotensin—aldosterone system in mild diabetic nephropathy. Nephron 31: 361–367, 1982.

    Article  Google Scholar 

  12. Wilson TW, Tan LK: Low plasma renin activity in diabetes: relation to urine prostaglandin excretion. Diabetes 34: 145–150, 1985.

    Article  PubMed  CAS  Google Scholar 

  13. Luetscher JA, Kraemer FB, Wilson DM, Schwartz HC, Bryer-Ash M: Increased plasma inactive renin in diabetes mellitus. N Engl J Med 312: 1412–1417, 1985.

    Article  PubMed  CAS  Google Scholar 

  14. Drury PL, Bodansky HJ, Oddie CJ, Cudworth AG, Edwards CRW: Increased plasma renin activity in type 1 diabetes with microvascular disease. Clin Endocrinol 16: 453, 1982.

    Article  CAS  Google Scholar 

  15. Ferriss JB, O’Hare JA, Cole M, Kingston SM, Twomey BM, O’Sullivan DJ: Blood pressure in diabetic patients: relationship with exchangeable sodium and renin activity. Diabetic Nephropathy 5: 27–30, 1986.

    Google Scholar 

  16. Walker WG, Hermann J, Murphy R, Patz A: Elevated blood pressure and angiotensin are associated with accelerated loss of renal function in diabetic nephropathy. In: Fourth Int Nutr Metab Renal Disease, Williamsburg, 1985, 80a.

    Google Scholar 

  17. Björck S, Delin K, Herlitz H, Larson O, Aurell M: Renin secretion in advanced diabetic nephropathy. Scand J Urol Nephrol 79: S53, 1984.

    Google Scholar 

  18. Ballermann BJ, Skorecki KL, Brenner BM: Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat. Am J Physiol 247: F110 — F116, 1984.

    PubMed  CAS  Google Scholar 

  19. Heidbreder E, Götz R, Schafferhans K, Heidland A: Diminished parathyroid gland responsiveness to hypocalcemia in diabetic patients with uremia. Nephron 42: 285–289, 1986.

    Article  PubMed  CAS  Google Scholar 

  20. Hasslacher Ch, Stech W, Wahl P, Ritz E: Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 28: 6–11, 1985.

    Article  PubMed  CAS  Google Scholar 

  21. Hasslacher Ch, Ritz E, Terpstra J, Gallasch G, Kunowski G, Rall C: Natural history of nephropathy in type I diabetes: relationship to metabolic control and blood pressure. Hypertension [Supp 2] 7:11–74–11–78, 1985.

    Google Scholar 

  22. Mogensen CE, Christensen CK: Blood pressure changes and renal function in incipient and overt diabetic nephropathy. Hypertension [Suppl 2] 7:11–64–11–73, 1985.

    Google Scholar 

  23. Mauer SM, Steffes MW, Ellen EN, Sutherland DER, Brown DM, Goetz FC: Structural—functional relationships in diabetic nephropathy. J Clin Invest 74: 1143–1155, 1984.

    Article  PubMed  CAS  Google Scholar 

  24. Ritz E, Strumpf C, Katz F, Wing AJ, Quellhorst E: Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients. Hypertension [Suppl 2] 7:11–118—II-124, 1985.

    Google Scholar 

  25. Strumpf C, Katz F, Wing AJ, Ritz E: Cardiovascular risk factors and cardiovascular death in hemodialyzed diabetic patients. Proc Eur Dial Transplant Assoc 21: 202–208, 1984.

    Google Scholar 

  26. Chou LM, Beyer MM, Butt KM, Manis T, Friedman EA: Hypertension jeopardizes diabetic patients following renal transplant. Trans Am Soc Artif Intern Organs 30: 473–478, 1984.

    PubMed  CAS  Google Scholar 

  27. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH: Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 105: 173–178, 1986.

    PubMed  CAS  Google Scholar 

  28. Munichoodappa D, D’Elia JA, Libertino JA, Gleason RE, Christlieb AR: Renal artery stenosis in hypertensive diabetics. J Urol 121: 555, 1978.

    Google Scholar 

  29. Chihara J, Takebayashi S, Taguchi T, Yokoyama K, Harada T, Naito S: Glomerulonephritis in diabetic patients and its effect on the prognosis. Nephron 43: 45–49, 1986.

    Article  PubMed  CAS  Google Scholar 

  30. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925–1930, 1986.

    Article  PubMed  CAS  Google Scholar 

  31. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612–619, 1985.

    Article  PubMed  CAS  Google Scholar 

  32. Ritz E, Hasslacher Ch: Genesis and treatment of hypertension in diabetes mellitus. Diabetic Nephropathy 3: 2, 1984.

    Google Scholar 

  33. Sato T, Nara Y, Note S, Yamori Y: Unproved glucose metabolism in hypertensive diabetic rats by antihypertensive treatment. In: 11th Scient Meet Int Soc Hypert, Heidelberg, August 1986, 0492a.

    Google Scholar 

  34. Topol EJ, Traili TA, Fortuin NJ: Hypertensive hypertrophie cardiomyopathy of the elderly. N Engl J Med 312:277-, 1985.

    Google Scholar 

  35. Massry SG, Feinstein EI, Goldstein DA: Early dialysis in diabetic patients with chronic renal failure. Nephron 23: 2–5, 1979.

    Article  PubMed  CAS  Google Scholar 

  36. Mathiesen ER, Hommel E, Kastrup J, Parving HH: The effect of acute arterial blood pressure reduction on kidney function in incipient and overt diabetic nephropathy. Diabetic Nephropathy 5: 45, 1986.

    Google Scholar 

  37. Cavallo T, Pinto JA, Rajaraman S: Immune complex disease complicating diabetic glomerulosclerosis. Am J Nephrol 4: 347–354, 1984.

    Article  PubMed  CAS  Google Scholar 

  38. Knowler WC, Bennett PH, Ballintine EJ: Increased incidence of retinopathy in diabetics with elevated blood pressure. N Engl J Med 302: 645–650, 1980.

    Article  PubMed  CAS  Google Scholar 

  39. Baldwin DS: Chronic gomerulonephritis: non-immunologic mechanisms of progressive glomerular damage. Kidney Int 21: 109–120, 1982.

    Article  PubMed  CAS  Google Scholar 

  40. Christensen CK, Mogensen CE: Effect of antihypertensive treatment on progression of incipient diabetic nephropathy. Hypertension [Suppl 2] 7:11–109–11–113, 1985.

    Google Scholar 

  41. Christensen CK, Mogensen CE: Long-term antihypertensive treatment reduces both baseline and exercise-induced microalbuminuria in diabetics with incipient nephropathy. Diabetic Nephropathy 5: 46–47, 1986.

    Google Scholar 

  42. Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293: 471–474, 1986.

    Article  Google Scholar 

  43. Dominguez JR, de la Calle H, Hurtado A, Robles HG, Sancho-Rof J: Effect of captopril on metabolic control in hypertensive patients with type II diabetes. In: Captopril symposium. London: Royal Academy of Physicians, 1985, 25a.

    Google Scholar 

  44. Elling H, Elling H: Penicillamine, captropril and hypoglycemia. Ann Intern Med 103: 644, 1985.

    PubMed  CAS  Google Scholar 

  45. Helgeland A, Hagelund CH, Strommen R, Tretli S: Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. Lancet 1: 872–875, 1984.

    Google Scholar 

  46. Rett K, Jauch W, Wicklemeyer M, Dietze G, Mehnert H: Experimental and human experienced with ACE inhibition in diabetes: evidence for improvement in glucose metabolism. In: Captopril symposium. London: Royal Academy of Physicians, 1985, 23a.

    Google Scholar 

  47. Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishiziaki M, Takahashi H, Sekino H, Sasaki Y: Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 313: 1617–1620, 1985.

    Article  PubMed  CAS  Google Scholar 

  48. Malaisse-Lagae F, Mathias PC, Malaisse WJ: Gatting and blocking of calcium channels by dishydropyridines in the pancreatic B-cell. Biochem Biophys Res Commun 123: 1062, 1984.

    Article  PubMed  CAS  Google Scholar 

  49. Bhatnagar SK, Amin MM, Al-Yusuf AR: Diabetogenic effects of nifedipine. Br Med J 289: 19, 1984.

    Article  CAS  Google Scholar 

  50. Abadie E, Villette JM, Gauveille C, Tabuteau F, Fiet J: Influence of nifedipine on carbohydrate metabolism in non-insulin-dependent diabetic patients. Diabete Metab 11: 141, 1985.

    PubMed  CAS  Google Scholar 

  51. Trost BN, Weidmann P: Effects of nitrendipine and other calcium antagonists on glucose metabolism in man. J Cardiovasc Pharmacol [Suppl 7] 6: 986, 1984.

    Article  Google Scholar 

  52. Roejdmark S, Andersson DE: Influence of verapamil on glucose tolerance. Acta Med Scand [Suppl 681] 215: 37, 1984.

    Article  Google Scholar 

  53. Hiedland A, Heidbreder E, Hörl WH, Schäfer R: Calcium antagonists in the treatment of hypertension. Contrib Nephrol 33: 254–269, 1982.

    Google Scholar 

Download references

Authors
  1. Eberhard Ritz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christoph Hasslacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Johannes Mann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Aarhus Kommunehospital, Second University Clinic of Internal Medicine, DK-8000, Aarhus C, Denmark

    Carl Erik Mogensen MD

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Ritz, E., Hasslacher, C., Mann, J. (1988). Hypertension in Diabetics with Renal Disease. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Topics in Renal Medicine, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1974-1_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1974-1_22

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1976-5

  • Online ISBN: 978-1-4757-1974-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation